期刊文献+

姜黄素抗急性髓系白血病作用机制及联合用药研究进展

Research Progress on the Mechanism of Action of Curcumin Against Acute Myeloid Leukemia and Its Combination Medication
原文传递
导出
摘要 姜黄素是从天然植物姜黄根茎中提取的一类活性成分,具有抗肿瘤、免疫调节、抗炎等药理作用,研究表明姜黄素通过多种机制发挥抗急性髓系白血病(AML)作用。对姜黄素通过抑制细胞增殖、诱导凋亡、免疫调节、逆转耐药性、抑制侵袭转移、调控信号通路等作用机制及联合用药抗AML进行综述,提出姜黄素的不足之处和亟待解决的问题,以期为姜黄素后续研究及临床应用提供思路及理论依据。 Curcumin is a class of active ingredients extracted from the rhizomes of the natural plant turmeric,which has pharmacological effects such as antitumor,immunomodulatory,and anti-inflammatory.Studies have shown that curcumin exerts anti-acute myeloid leukemia(AML)effects through a variety of mechanisms.The mechanism of action of curcumin by inhibiting cell proliferation,inducing apoptosis,immunomodulation,reversing drug resistance,inhibiting invasion and metastasis,regulating signaling pathways,and the combination of anti-AML are summarized,and the shortcomings and problems to be solved urgently are put forward,in order to provide ideas and theoretical basis for the follow-up research and clinical application of curcumin.
作者 林智敏 周云龙 曾英坚 LIN Zhimin;ZHOU Yunlong;ZENG Yingjian(Graduate School,Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,China;Department of Hematology,Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine,Nanchang 330006,China)
出处 《现代中药研究与实践》 CAS 2024年第4期92-97,共6页 Research and Practice on Chinese Medicines
基金 国家自然科学基金地区基金项目(82260914) 中医优势病种培育项目(赣财社指[2022]56号)。
关键词 姜黄素 急性髓系白血病(AML) 作用机制 联合用药 Curcumin AML mechanism of action combination medications
  • 相关文献

参考文献11

二级参考文献163

  • 1万新焕,王瑜亮,周长征,郭浩,马山,王立柱.丹参化学成分及其药理作用研究进展[J].中草药,2020,51(3):788-798. 被引量:418
  • 2谯明鸣,熊亮,刘宇,郭力,刘菲,彭成.姜黄与莪术活血功效差异的物质基础研究[J].世界科学技术-中医药现代化,2020,22(7):2531-2539. 被引量:12
  • 3张洪英.中药姜黄的研究进展[J].菏泽医学专科学校学报,2001,13(4):84-87. 被引量:15
  • 4李英华,罗建民.白血病形成中JAK/STAT信号通路的持续激活[J].国际病理科学与临床杂志,2006,26(5):398-402. 被引量:6
  • 5Komblau S M,Qiu Y H,Bekele B N,et al. Studying the rightcell in acute myelogenous leukemia : dynamic changes of apoptosisand signal transduction pathway protein expression in chemotherapyresistant ex-vivo selected “survivor cells” [ J]. Cell Cycle,2006, 5(23):2769 -77. 被引量:1
  • 6Kobune M, Takimoto R, Murase K, et al. Drug resistance is dra-matically restored by hedgehog inhibitors in CD34 + leukemic cells[J]. Cancer Sci, 2009,100(5) : 948 -55. 被引量:1
  • 7Anand P, Sundaram C,Jhurani S, et al. Curcumin and cancer:an “ old-age ” disease with an “ age-old ” solution [ J]. CancerLett, 2008, 267(1) :133 -64. 被引量:1
  • 8Strimpakos A S, Sharma R A. Curcumin: preventive and thera-peutic properties in laboratory studies and clinical trials[ J] . An-tioxid Redox Signal, 2008,10(3) :511 -45. 被引量:1
  • 9Aggarwal B B,Shishodia S, Takada Y, et al. Curcumin suppres-ses the paclitaxel-induced nuclear factor-kappaB pathway in breastcancer cells and inhibits lung metastasis of human breast cancer innude mice[ J]. Clin Cancer Res,2005,11 (20) :7490 ~ 8. 被引量:1
  • 10Sen S, Sharma H, Singh N. Curcumin enhances Vinorelbine me-diated apoptosis in NSCLC cells by the mitochondrial pathway [J].Biochem Biophys Res Commun, 2005 ,331 (4) : 1245 — 52. 被引量:1

共引文献182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部